# Glatiramer Acetate

NDC: 0378-6961
Generic name: Glatiramer
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: INJECTION, SOLUTION
Routes: SUBCUTANEOUS
Marketing started: 20171004

FDA application: ANDA206936

## Active ingredients

- GLATIRAMER ACETATE: 40 mg/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-6961"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-6961
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=456a34c7-8511-4000-99a7-ad8f8de6d35e